{"id":2608,"date":"2026-09-23T12:18:34","date_gmt":"2026-09-23T12:18:34","guid":{"rendered":"https:\/\/nhdbio.com\/?p=2608"},"modified":"2026-09-23T12:18:34","modified_gmt":"2026-09-23T12:18:34","slug":"fehlerbehebung-bei-der-peptid-lc-ms-verschleppung-bei-der-blindinjektion","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/peptide-lcms-carryover-blank-injection-troubleshooting\/","title":{"rendered":"Verschleppung bei der Peptid-LC\u2013MS: Was ein positiver Leerwert aussagt"},"content":{"rendered":"

A target peak in a blank following a peptide standard is not evidence that the blank contains a new biological signal. Material from the preceding injection may remain in the autosampler, flow path or column. A useful carryover investigation asks where the residual signal originates<\/strong> and how much remains in subsequent blanks under the assay’s actual injection sequence.<\/p>\n

What a neuropeptide Y experiment measured<\/h2>\n

In a published troubleshooting study, researchers injected 1 \u00b5L of 1 \u00b5M neuropeptide Y (NPY)<\/strong> into an LC\u2013Orbitrap system and measured the NPY peak in subsequent blank runs. They defined carryover as the blank-peak abundance divided by abundance in the most recent NPY sample. The first blank was 4.05%<\/strong> of the preceding 1 \u00b5M sample. The same paper reports 0.36%<\/strong> and 0.47%<\/strong> for 5 and 10 \u00b5M NPY standards, respectively, under its tested conditions. A smaller percentage after a higher-concentration injection does not mean less absolute residue; the denominator changed. [1, Results and Discussion, Table 1]<\/p>\n\n\n\n\n\n\n\n
NPY standard, 1 \u00b5L injection<\/th>\nFirst-blank carryover ratio in study<\/th>\nInterpretation boundary<\/th>\n<\/tr>\n<\/thead>\n
1 \u00b5M<\/td>\n4.05%<\/td>\nRatio to that preceding standard’s signal<\/td>\n<\/tr>\n
5 \u00b5M<\/td>\n0.36%<\/td>\nDifferent denominator and possibly different absolute residue<\/td>\n<\/tr>\n
10 \u00b5M<\/td>\n0.47%<\/td>\nAssay-specific ratio, not a universal acceptance limit<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

The investigators then changed parts of the flow path systematically. An experiment avoiding use of the sample needle during a blank reduced the 1 \u00b5M carryover estimate from 4.05% to 3.05%<\/strong>. Further comparisons without the column and after replacing needle and high-pressure valve seals implicated more than one surface. In the paper’s optimized configuration, which included seal replacement and removal of the guard column, the first blank was 2.15%<\/strong> and later blanks were below 0.9%<\/strong>. The 2.15% result cannot be attributed to seal replacement alone. These interventions locate contributions in that instrument; they do not provide a cleaning recipe for every LC\u2013MS platform. [1, \u201cStrategy for identifying carry-over sites,\u201d Experiments 1\u20133 and Table 4]<\/p>\n

A controlled troubleshooting sequence<\/h2>\n

Run a blank after a defined high standard and record the target’s retention time, mass\/transition and signal. Repeat enough blanks to see whether signal decays; do not assume one blank clears it. Check a blank delivered without the normal sample path, where the instrument permits, to separate an ion-source or solvent background from the LC path. Change one component or wash condition at a time<\/strong>: needle path, valve or seal, tubing, guard column and analytical column. Document the same injected mass, blank timing, gradient and integration rule in each comparison.<\/p>\n

Carryover and surface adsorption are related but answer different questions. Adsorption may lower signal in the current sample; later desorption can raise signal in the next blank. A blank can also be contaminated during preparation, so include independently prepared solvent and matrix blanks. Define a method-specific acceptance criterion relative to the lower limit of quantification and intended sample sequence; do not adopt the paper’s 1% target as a universal specification. The LC\u2013MS identity guide<\/a> helps separate identity evidence from a coincident peak.<\/p>\n

Compare the right denominators<\/h3>\n

The NPY paper’s percentages use the preceding sample peak<\/strong> as denominator. For regulatory bioanalytical validation, ICH M10<\/a> instead specifies a blank after the highest calibrator and compares its analyte response with the LLOQ response<\/strong> (and internal-standard response separately). These are different tests; a 2% blank-to-high-standard ratio cannot be judged against the M10 threshold without the LLOQ signal. M10’s published thresholds are 20% of analyte response at LLOQ and 5% of internal-standard response in that context. They are not universal targets for non-regulatory research. [2, \u00a73.2.6]<\/p>\n

Before accepting a run, preserve the sequence: blank before high sample, high sample, first blank, later blanks and next low sample. Record both the blank\/high ratio and blank\/LLOQ ratio when a validated LLOQ exists. This keeps an apparently small percentage from hiding a large bias at the low end.<\/p>\n

Evidence limit<\/h2>\n

This is a single NPY LC\u2013MS setup<\/strong>, not a test of NHD lots or a general performance claim for all peptides. It is valuable for its experimental logic: isolate the source, repeat the blank sequence and verify the effect of each intervention. A laboratory should validate its own wash solvents for compatibility with the column, seals and mass-spectrometer source before implementation.<\/p>\n

Primary source and claim trail<\/h2>\n
    \n
  1. Troubleshooting Carry-Over in the LC-MS Analysis of Biomolecules: The Case of Neuropeptide Y<\/em><\/a>. Mass Spectrometry<\/em>. 2020. DOI 10.5702\/massspectrometry.S0083<\/a>, PMID 33299733. Locations:<\/strong> Results and Discussion\/Table 1 (1 \u00b5L, 1\/5\/10 \u00b5M, ratio definition and 4.05\/0.36\/0.47%); \u201cStrategy for identifying carry-over sites,\u201d Experiments 1\u20133 (needle and column isolation); Table 4 (post-seal-replacement blanks). Primary full text checked.<\/li>\n
  2. International Council for Harmonisation. ICH M10: Bioanalytical Method Validation and Study Sample Analysis<\/em><\/a>, final guideline, 2022. Location:<\/strong> \u00a73.2.6 (carryover definition, blank after ULOQ, LLOQ and internal-standard denominators). Used only as a regulatory comparator, not to reinterpret the NPY experiment.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    A target peak in a blank following a peptide standard is not evidence that the blank contains a new biological signal. Material from the preceding injection may remain in the autosampler, flow path or column. A useful carryover investigation asks where the residual signal originates and how much remains in subsequent blanks under the assay’s […]<\/p>\n","protected":false},"author":1,"featured_media":2607,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"","pim_article_type":"","pim_evidence_level":"","pim_reviewer":"Codex AI-assisted editorial review","pim_reviewed_date":"2026-09-23T20:13:54+08:00","pim_editorial_note":"","pim_review_status":"reviewed","pim_review_reason":"English source and numeric audit, independent seven-language and 135 numeric-exception AI reviews, 70\/70 authenticated localized previews with 2,607\/2,607 body nodes visible, generated-image provenance and visual review, internal-link and private-draft dedup checks completed. Author is existing NHD Technical Team WP user #1. Prepublication SEO fields and expected slug checked; verify public canonical, hreflang, schema, robots and sitemap immediately after this post publishes, and conditionally roll back on failure. Backup is listed in All-in-One WP Migration; full restore was not rehearsed. No human or native-language review was performed. V9 PIM source normalization audit: one trailing ASCII space was removed from 1 source note in the live draft metadata; both source rows remain complete and semantically identical to the reviewed manifest. Manifest PIM SHA e36421dd4ff7c3d906ea4964605eec9e42d161a77a65f4eb6e4d37de2510df8b; live PIM SHA 766320e60d188b44f51ee3c21001418fb7d100ea6bfcdeff74d1ab0785701a71. This is an AI-assisted review, not a claim of human review.","pim_creation_method":"AI-assisted editorial draft; independent Codex source, image and seven-language review; human professional review not claimed","pim_sources":"[{\"title\":\"Troubleshooting Carry-Over in the LC-MS Analysis of Biomolecules: The Case of Neuropeptide Y\",\"url\":\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7709882\/\",\"note\":\"Source 1. Results and Discussion\/Table 1 (1 \u00b5L, 1\/5\/10 \u00b5M, ratio definition and 4.05\/0.36\/0.47%); \u201cStrategy for identifying carry-over sites,\u201d Experiments 1\u20133 (needle and column isolation); Table 4 (post-seal-replacement blanks).\"},{\"title\":\"International Council for Harmonisation. ICH M10: Bioanalytical Method Validation and Study Sample Analysis, final guideline, 2022. Location: \u00a73.2.6 (carryover definition, blank after ULOQ, LLOQ and internal-standard den\",\"url\":\"https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf\",\"note\":\"Source 2. \u00a73.2.6 (carryover definition, blank after ULOQ, LLOQ and internal-standard denominators). Used only as a regulatory comparator, not to reinterpret the NPY experiment.\"}]","footnotes":""},"categories":[1],"tags":[],"class_list":["post-2608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\nPeptide LC\u2013MS Carryover: Diagnose the Blank After a Sample<\/title>\n<meta name=\"description\" content=\"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/fehlerbehebung-bei-der-peptid-lc-ms-verschleppung-bei-der-blindinjektion\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You\" \/>\n<meta property=\"og:description\" content=\"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/fehlerbehebung-bei-der-peptid-lc-ms-verschleppung-bei-der-blindinjektion\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-23T12:18:34+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1774\" \/>\n\t<meta property=\"og:image:height\" content=\"887\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You\",\"datePublished\":\"2026-09-23T12:18:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\"},\"wordCount\":773,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\",\"name\":\"Peptide LC\u2013MS Carryover: Diagnose the Blank After a Sample\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"datePublished\":\"2026-09-23T12:18:34+00:00\",\"description\":\"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/featured-3.png\",\"width\":1774,\"height\":887,\"caption\":\"Conceptual illustration of sample carryover along an autosampler pathway. Not experimental data.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/peptide-lcms-carryover-blank-injection-troubleshooting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Verschleppung bei der Peptid-LC\u2013MS: Was ein positiver Leerwert aussagt","description":"Eine Neuropeptid-Y-Studie verfolgte Verschleppung \u00fcber Nadel, Dichtungen, Leitungen und S\u00e4ule; Leerl\u00e4ufe helfen bei der Diagnose.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/fehlerbehebung-bei-der-peptid-lc-ms-verschleppung-bei-der-blindinjektion\/","og_locale":"de_DE","og_type":"article","og_title":"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You","og_description":"A neuropeptide Y study traced carryover through needle, seals, lines and column. Use its controlled blank-injection logic without copying its limits.","og_url":"https:\/\/nhdbio.com\/de\/fehlerbehebung-bei-der-peptid-lc-ms-verschleppung-bei-der-blindinjektion\/","og_site_name":"NHD","article_published_time":"2026-09-23T12:18:34+00:00","og_image":[{"width":1774,"height":887,"url":"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","type":"image\/png"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You","datePublished":"2026-09-23T12:18:34+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/"},"wordCount":773,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","articleSection":["Uncategorized"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/","url":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/","name":"Verschleppung bei der Peptid-LC\u2013MS: Was ein positiver Leerwert aussagt","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","datePublished":"2026-09-23T12:18:34+00:00","description":"Eine Neuropeptid-Y-Studie verfolgte Verschleppung \u00fcber Nadel, Dichtungen, Leitungen und S\u00e4ule; Leerl\u00e4ufe helfen bei der Diagnose.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/featured-3.png","width":1774,"height":887,"caption":"Conceptual illustration of sample carryover along an autosampler pathway. Not experimental data."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/peptide-lcms-carryover-blank-injection-troubleshooting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Peptide LC\u2013MS Carryover: What a Positive Blank Can Tell You"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/2608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=2608"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/2608\/revisions"}],"predecessor-version":[{"id":2641,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/2608\/revisions\/2641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/2607"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=2608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=2608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=2608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}